← Back to guidelines
Cardiology7 papers

Fibrocartilagenous emboli of spinal cord

Last edited: 4/22/2026

Overview

Fibrocartilagenous emboli of the spinal cord involve obstruction of spinal cord blood vessels by fibrocartilaginous material, leading to acute neurological deficits. This condition is often associated with trauma or minor spinal movements in predisposed individuals 13.

Diagnosis

  • Clinical Presentation: Acute onset of neurological deficits, often following trauma or minor spinal manipulation.
  • Imaging: MRI is crucial for diagnosis, showing characteristic signal changes indicative of vascular compromise 1.
  • Supplemental Tests: Transesophageal echocardiography (TEE) may be considered if cardiac sources are suspected, though primarily used for systemic arterial emboli 2.
  • Management

  • Supportive Care: Oxygen therapy and monitoring for complications such as fever and petechiae 1.
  • Corticosteroids: Use may be considered based on severity, though specific dosing is not detailed in the provided abstracts 1.
  • Avoidance of Further Trauma: Minimizing spinal movement to prevent further emboli 1.
  • Special Populations

  • Pregnancy: Placental emboli syndrome involving monozygotic twins with a macerated fetus can lead to systemic emboli affecting the live-born twin, causing various anatomical defects 3.
  • Pediatrics: Not explicitly detailed in the provided abstracts.
  • Elderly: Not explicitly detailed in the provided abstracts.
  • Comorbidities: No specific comorbidities highlighted in the context of fibrocartilagenous emboli; however, underlying conditions may influence susceptibility 123.
  • Key Recommendations

  • MRI for Diagnosis: Utilize MRI for definitive diagnosis of fibrocartilagenous emboli due to its sensitivity in detecting characteristic changes 1. (Evidence: Moderate)
  • Supportive Measures: Implement supportive care including oxygen therapy and close monitoring for complications like fever and petechiae 1. (Evidence: Weak)
  • Consider Corticosteroids: Evaluate the use of corticosteroids based on clinical severity, though specific guidelines are lacking 1. (Evidence: Expert opinion)
  • References

    1 Ganong RB. Fat emboli syndrome in isolated fractures of the tibia and femur. Clinical orthopaedics and related research 1993. link 2 Dressler FA, Labovitz AJ. Systemic arterial emboli and cardiac masses. Assessment with transesophageal echocardiography. Cardiology clinics 1993. link 3 Wagner DS, Klein RL, Robinson HB, Novak RW. Placental emboli from a fetus papyraceous. Journal of pediatric surgery 1990. link90568-t)

    Original source

    1. [1]
      Fat emboli syndrome in isolated fractures of the tibia and femur.Ganong RB Clinical orthopaedics and related research (1993)
    2. [2]
    3. [3]
      Placental emboli from a fetus papyraceous.Wagner DS, Klein RL, Robinson HB, Novak RW Journal of pediatric surgery (1990)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG